Potentiating the Immune Responses of HBsAg-VLP Vaccine Using a Polyphosphoester-Based Cationic Polymer Adjuvant
ACS Applied Materials & Interfaces · 2023
DOI: 10.1021/acsami.3c07491 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, 2023. Written by Xuhan Liu and 6 co-authors. Institution: Department of Chemical Engineering, Imperial College London, South Kensington Campus, London SW7 2AZ, U.K. Major MEDLINE topics: Hepatitis B Surface Antigens, Vaccines, Virus-Like Particle. Cited 11 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY 4.0). Funded by: Engineering and Physical Sciences Research Council, Department of Health and Social Care, Sanming Project of Medicine in Shenzen Municipality.
Abstract (original language)
Virus-like particle (VLP)-based vaccines are required to be associated with a suitable adjuvant to potentiate their immune responses. Herein, we report a novel, biodegradable, and biocompatible polyphosphoester-based amphiphilic cationic polymer, poly(ethylene glycol)-b-poly(aminoethyl ethylene phosphate) (PEG-PAEEP), as a Hepatitis B surface antigen (HBsAg)-VLP vaccine adjuvant. The polymer adjuvant effectively bound with HBsAg-VLP through electrostatic interactions to form a stable vaccine nanoformulation with a net positive surface charge. The nanoformulations exhibited enhanced cellular uptake by macrophages. HBsAg-VLP/PEG-PAEEP induced a significantly higher HBsAg-specific IgG titer in mice than HBsAg-VLP alone after second immunization, indicative of the antigen-dose sparing advantage of PEG-PAEEP. Furthermore, the nanoformulations exhibited a favorable biocompatibility and in vivo tolerability. This work presents the PEG-PAEEP copolymer as a promising vaccine adjuvant and as a potentially effective alternative to aluminum adjuvants.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemical Engineering, Imperial College London, South Kensington Campus, London SW7 2AZ, U.K.
- Department of Emergency Medicine, Shenzhen University General Hospital, Shenzhen University, Shenzhen 518051, China.
- AIM Honesty Biopharmaceutical Co., Ltd, Dalian 116620, China.
- Department of Infectious Diseases, Imperial College London, London W12 0NN, U.K.
ORCID profiles: Rongjun Chen
Funding
- Engineering and Physical Sciences Research Council
- Department of Health and Social Care
- Sanming Project of Medicine in Shenzen Municipality
- Shenzhen High-end Talent Scientific Research
Cite
APA
Liu, X., Liu, Y., Yang, X., Lu, X., Xu, X. N., Zhang, J., & Chen, R. (2023). Potentiating the Immune Responses of HBsAg-VLP Vaccine Using a Polyphosphoester-Based Cationic Polymer Adjuvant. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c07491
Vancouver
Liu X, Liu Y, Yang X, Lu X, Xu XN, Zhang J, et al. Potentiating the Immune Responses of HBsAg-VLP Vaccine Using a Polyphosphoester-Based Cationic Polymer Adjuvant. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.3c07491
BibTeX
@article{Liu2023,
author = {Liu, Xuhan and Liu, Yifan and Yang, Xiaoyu and Lu, Xinyu and Xu, Xiao-Ning and Zhang, Jiancheng and Chen, Rongjun},
title = {Potentiating the Immune Responses of HBsAg-VLP Vaccine Using a Polyphosphoester-Based Cationic Polymer Adjuvant},
journal = {ACS Applied Materials & Interfaces},
year = {2023},
doi = {10.1021/acsami.3c07491}
}
EUVIMED